Parkinson's Disease Management Guidelines

Initial Treatment Approach

The American Academy of Neurology recommends levodopa as the most effective drug for treating motor symptoms of Parkinson's disease and should be offered as first-line therapy for most newly diagnosed patients 1, 2, 3

Patients should take levodopa medications at least 30 minutes before meals to avoid interactions with dietary proteins that reduce absorption and efficacy 1, 3
For patients experiencing motor fluctuations, implementing a protein redistribution diet (low-protein breakfast and lunch, normal protein intake at dinner) improves motor function and increases "ON" time 1, 3
The recommended daily protein intake should be 0.8-1.0 g/kg of body weight 1
Monitor for potential complications of protein redistribution including weight loss, micronutrient deficits, hunger before dinner, and dyskinesias 1, 3

For patients with troublesome dyskinesias, reducing levodopa doses may be considered 1, 3
Deep brain stimulation (DBS) can be considered for advanced motor fluctuations resistant to oral medication adjustments 1, 3

When considering DBS for advanced PD, either subthalamic nucleus (STN) or globus pallidus internus (GPi) targets can be selected for treating motor symptoms 1, 3
STN DBS should be preferred when medication reduction is a primary goal 1
If there are significant concerns about cognitive decline, GPi DBS may be preferable 1, 2, 3
If there is significant concern about depression risk, GPi stimulation should be considered over STN 1

For REM sleep behavior disorder (RBD) associated with Parkinson's disease, melatonin (3-12 mg at bedtime) is recommended, especially for older patients, as it is only mildly sedating 2, 3, 4
Clonazepam (0.5-2.0 mg 30 minutes before bedtime) is commonly used but has side effects including morning sedation, gait imbalance/falls, depression, and cognitive disturbances 3, 4

Medical nutrition therapy should be provided to improve well-being and quality of life, tailored to individual requirements 1
For patients with dysphagia, rehabilitation treatment should be advised after multidimensional assessment of swallowing function 1, 5
Patients on levodopa should be monitored for homocysteine levels and vitamin B status, as levodopa can cause hyperhomocysteinemia 1, 3
Monitor for side effects of PD medications that might influence nutritional status, including nausea, vomiting, abdominal pain, dyspepsia, constipation, weight decrease, dry mouth, and anorexia 1, 3

Strict low-protein diets are not supported by evidence and should be avoided 1, 3
Increasing doses of levodopa over time are associated with higher risk for malnutrition, requiring careful monitoring 1, 2, 3